Works by Tomita, Aiko

Results: 4

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY.
Published in:
Clinical & Experimental Nephrology, 2024, v. 28, n. 6, p. 588, doi. 10.1007/s10157-024-02489-4
By:
- Nangaku, Masaomi;
- Herrington, William G.;
- Goto, Shinya;
- Maruyama, Shoichi;
- Kashihara, Naoki;
- Ueki, Kohjiro;
- Wada, Jun;
- Watada, Hirotaka;
- Nakashima, Eitaro;
- Lee, Ryonfa;
- Massey, Dan;
- Mayne, Kaitlin J.;
- Tomita, Aiko;
- Haynes, Richard;
- Hauske, Sibylle J.;
- Kadowaki, Takashi
Publication type:
Article
Antithrombotic Therapy for Prevention of Various Thrombotic Diseases.
Published in:
Drug Development Research, 2013, v. 74, n. 8, p. 568, doi. 10.1002/ddr.21116
By:
- Goto, Shinya;
- Tomita, Aiko
Publication type:
Article
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 435, doi. 10.1016/S0009-9236(03)00014-6
By:
- Watanabe, Ichiro;
- Tomita, Aiko;
- Shimizu, Miho;
- Sugawara, Mie;
- Yasumo, Hiroaki;
- Koishi, Ryuta;
- Takahashi, Tohru;
- Miyoshi, Kaoru;
- Nakamura, Kouichi;
- Izumi, Takashi;
- Matsushita, Yasuyuki;
- Furukawa, Hidehiko;
- Haruyama, Hideyuki;
- Koga, Teiichiro
Publication type:
Article
New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome.
Published in:
Clinical Cardiology, 2014, v. 37, n. 3, p. 178, doi. 10.1002/clc.22233
By:
- Goto, Shinya;
- Tomita, Aiko
Publication type:
Article

Works by Tomita, Aiko

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY.

Antithrombotic Therapy for Prevention of Various Thrombotic Diseases.

A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome.